Boston Financial Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7.99M | Buy |
80,341
+2,674
| +3% | +$276K | 0.24% | 79 |
|
|
2024
Q3 | $8.82M | Sell |
77,667
-4,302
| -5% | -$511K | 0.26% | 78 |
|
|
2024
Q2 | $10.1M | Buy |
81,969
+5,424
| +7% | +$699K | 0.32% | 70 |
|
|
2024
Q1 | $10.1M | Sell |
76,545
-180
| -0.2% | -$22.2K | 0.32% | 69 |
|
|
2023
Q4 | $8.36M | Buy |
76,725
+2,836
| +4% | +$294K | 0.28% | 71 |
|
|
2023
Q3 | $7.61M | Sell |
73,889
-446
| -0.6% | -$48.1K | 0.28% | 73 |
|
|
2023
Q2 | $8.58M | Sell |
74,335
-2,479
| -3% | -$281K | 0.31% | 71 |
|
|
2023
Q1 | $8.17M | Sell |
76,814
-3,450
| -4% | -$372K | 0.32% | 71 |
|
|
2022
Q4 | $8.91M | Buy |
80,264
+678
| +0.9% | +$69.3K | 0.36% | 66 |
|
|
2022
Q3 | $6.85M | Buy |
79,586
+10,518
| +15% | +$939K | 0.3% | 70 |
|
|
2022
Q2 | $6.3M | Buy |
69,068
+1,825
| +3% | +$162K | 0.27% | 77 |
|
|
2022
Q1 | $5.52M | Buy |
67,243
+8,226
| +14% | +$649K | 0.21% | 81 |
|
|
2021
Q4 | $4.52M | Buy |
59,017
+980
| +2% | +$78.1K | 0.16% | 80 |
|
|
2021
Q3 | $4.36M | Buy |
58,037
+2,240
| +4% | +$170K | 0.18% | 78 |
|
|
2021
Q2 | $4.34M | Sell |
55,797
-2,453
| -4% | -$182K | 0.18% | 80 |
|
|
2021
Q1 | $4.29M | Sell |
58,250
-2,554
| -4% | -$188K | 0.19% | 77 |
|
|
2020
Q4 | $4.75M | Sell |
60,804
-3,771
| -6% | -$288K | 0.22% | 77 |
|
|
2020
Q3 | $5.11M | Sell |
64,575
-1,758
| -3% | -$138K | 0.25% | 73 |
|
|
2020
Q2 | $4.89M | Sell |
66,333
-1,859
| -3% | -$140K | 0.26% | 72 |
|
|
2020
Q1 | $5.01M | Buy |
68,192
+3,863
| +6% | +$304K | 0.32% | 67 |
|
|
2019
Q4 | $5.58M | Buy |
64,329
+572
| +0.9% | +$47K | 0.31% | 76 |
|
|
2019
Q3 | $5.12M | Sell |
63,757
-1,467
| -2% | -$118K | 0.29% | 82 |
|
|
2019
Q2 | $5.22M | Sell |
65,224
-6,153
| -9% | -$471K | 0.3% | 82 |
|
|
2019
Q1 | $5.67M | Buy |
71,377
+118
| +0.2% | +$8.83K | 0.34% | 80 |
|
|
2018
Q4 | $5.2M | Sell |
71,259
-1,015
| -1% | -$71.7K | 0.36% | 81 |
|
|
2018
Q3 | $4.89M | Buy |
72,274
+7,319
| +11% | +$466K | 0.29% | 94 |
|
|
2018
Q2 | $3.76M | Sell |
64,955
-3,890
| -6% | -$219K | 0.25% | 100 |
|
|
2018
Q1 | $3.58M | Sell |
68,845
-30,079
| -30% | -$1.62M | 0.24% | 107 |
|
|
2017
Q4 | $5.31M | Sell |
98,924
-24,610
| -20% | -$1.36M | 0.36% | 91 |
|
|
2017
Q3 | $7.55M | Sell |
123,534
-10,271
| -8% | -$623K | 0.54% | 72 |
|
|
2017
Q2 | $8.18M | Sell |
133,805
-16,230
| -11% | -$988K | 0.59% | 63 |
|
|
2017
Q1 | $9.1M | Sell |
150,035
-6,679
| -4% | -$405K | 0.68% | 53 |
|
|
2016
Q4 | $8.8M | Sell |
156,714
-2,592
| -2% | -$152K | 0.69% | 45 |
|
|
2016
Q3 | $9.49M | Sell |
159,306
-5,988
| -4% | -$350K | 0.77% | 31 |
|
|
2016
Q2 | $9.09M | Buy |
165,294
+14,950
| +10% | +$796K | 0.74% | 36 |
|
|
2016
Q1 | $7.59M | Sell |
150,344
-2,239
| -1% | -$110K | 1.14% | 22 |
|
|
2015
Q4 | $7.69M | Sell |
152,583
-21,266
| -12% | -$1.07M | 1.1% | 23 |
|
|
2015
Q3 | $8.19M | Buy |
173,849
+5,508
| +3% | +$293K | 1.16% | 20 |
|
|
2015
Q2 | $9.14M | Sell |
168,341
-35
| -0% | -$1.96K | 1.18% | 18 |
|
|
2015
Q1 | $9.23M | Sell |
168,376
-365
| -0.2% | -$20.7K | 1.16% | 20 |
|
|
2014
Q4 | $9.14M | Buy |
168,741
+6,243
| +4% | +$348K | 1.15% | 19 |
|
|
2014
Q3 | $9.19M | Buy |
162,498
+5,140
| +3% | +$289K | 1.21% | 19 |
|
|
2014
Q2 | $8.69M | Buy |
157,358
+3,799
| +2% | +$207K | 1.15% | 20 |
|
|
2014
Q1 | $8.32M | Buy |
153,559
+14,832
| +11% | +$768K | 1.11% | 20 |
|
|
2013
Q4 | $6.63M | Buy |
138,727
+3,036
| +2% | +$139K | 0.91% | 33 |
|
|
2013
Q3 | $6.16M | Buy |
135,691
+1,271
| +0.9% | +$58K | 0.93% | 31 |
|
|
2013
Q2 | $5.96M | Buy |
+134,420
| New | +$6M | 0.92% | 31 |
|
Other funds holding MRK
Boston Financial Management's MRK Position: Q4 2024 in Review
Boston Financial Management increased its Merck (MRK) stake by 3.4% in Q4 2024, buying an estimated $276K and bringing the position to 80,341 shares worth $7.99M. The position accounts for 0.24% of the portfolio, ranked #79.
Boston Financial Management first reported a position in MRK in Q2 2013 and has held it in 47 quarters since. The position peaked at $10.1M in Q2 2024. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.
- Boston Financial Management held 80,341 shares of Merck worth $7.99M as of Q4 2024.
- Boston Financial Management bought 2,674 Merck shares in Q4 2024, an estimated $276K.
- Merck made up 0.24% of Boston Financial Management's portfolio in Q4 2024, its #79 holding.
- Boston Financial Management first reported a position in Merck in Q2 2013 and has held it in 47 quarters since.
- Boston Financial Management's Merck position peaked at $10.1M in Q2 2024.
- 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.